Natural history of chronic hepatitis B REVEALed
- PMID: 21323729
- DOI: 10.1111/j.1440-1746.2011.06695.x
Natural history of chronic hepatitis B REVEALed
Abstract
Chronic hepatitis B is a worldwide public health challenge. Knowledge of natural history of chronic hepatitis B is important for the management of the disease. A community-based prospective cohort study was carried out to evaluate the risk predictors of progression of chronic hepatitis B in Taiwan. A total of 23,820 participants were enrolled in 1991-1992 from seven townships in Taiwan. Their serum samples were collected at study entry and tested for hepatitis B surface antigen (HBsAg) and e antigen (HBeAg), antibodies against hepatitis C virus (anti-HCV), alanine aminotransferase (ALT), and α-fetoprotein (AFP). A subcohort of 3653 male and female participants who were seropositive for HBsAg and seronegative for anti-HCV was included in the Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer-Hepatitis B Virus (REVEAL-HBV) study. Newly developed cases of cirrhosis and hepatocellular carcinoma (HCC) were ascertained through follow-up examination and data linkage with profiles of the National Cancer Registry, National Health Insurance Database and Death Certification System. The incidence of both HCC and cirrhosis were significantly associated with serum HBV DNA levels in a dose-response relationship from <300 (undetectable) to ≥1,000,000 copies/mL. The biological gradients remained significant (P<0.001) after adjustment for age, sex, habits of cigarette smoking and alcohol drinking, HBeAg serostatus, and serum ALT level at cohort entry. A significant association with risk of cirrhosis and HCC was also observed for HBV genotype, precore G1896A mutant and basal core promoter A1762T/G1764A double mutant. Nomograms have been developed for the long-term risk prediction of cirrhosis and HCC for patients with chronic hepatitis B. Inactive carriers of HBV have an increased HCC incidence and liver-related mortality than HBsAg-seronegative controls. Serum HBV DNA level at study entry is a major predictor of spontaneous seroclearance of HBeAg, HBV DNA and HBsAg. These findings may inform the effective and efficient management of chronic hepatitis B.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
Similar articles
-
Natural history of chronic hepatitis B: what exactly has REVEAL revealed?Liver Int. 2012 Oct;32(9):1333-41. doi: 10.1111/j.1478-3231.2012.02805.x. Epub 2012 Apr 17. Liver Int. 2012. PMID: 22510145 Review.
-
Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance: a community-based follow-up study.Gastroenterology. 2010 Aug;139(2):474-82. doi: 10.1053/j.gastro.2010.04.048. Epub 2010 Apr 29. Gastroenterology. 2010. PMID: 20434450
-
Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.Gastroenterology. 2010 May;138(5):1747-54. doi: 10.1053/j.gastro.2010.01.042. Epub 2010 Jan 28. Gastroenterology. 2010. PMID: 20114048
-
Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.Gastroenterology. 2011 Oct;141(4):1240-8, 1248.e1-2. doi: 10.1053/j.gastro.2011.06.036. Epub 2011 Jun 22. Gastroenterology. 2011. PMID: 21703214
-
Hepatitis B viral factors and clinical outcomes of chronic hepatitis B.J Biomed Sci. 2008 Mar;15(2):137-45. doi: 10.1007/s11373-007-9225-8. Epub 2007 Dec 5. J Biomed Sci. 2008. PMID: 18058038 Review.
Cited by
-
Similar response to entecavir 0.5 and 1.0 mg in treatment-naïve chronic hepatitis B patients: a case-control study.Dig Dis Sci. 2014 Jan;59(1):168-73. doi: 10.1007/s10620-013-2940-2. Epub 2013 Nov 19. Dig Dis Sci. 2014. PMID: 24248420
-
Virological Changes of Chronic Hepatitis B Patients with Minimally Elevated Levels of Alanine Aminotransferase: A Meta-Analysis and Systematic Review.Can J Gastroenterol Hepatol. 2022 Nov 16;2022:7499492. doi: 10.1155/2022/7499492. eCollection 2022. Can J Gastroenterol Hepatol. 2022. PMID: 36439633 Free PMC article.
-
The Yin and the Yang of Treatment for Chronic Hepatitis B-When to Start, When to Stop Nucleos(t)ide Analogue Therapy.Viruses. 2020 Aug 25;12(9):934. doi: 10.3390/v12090934. Viruses. 2020. PMID: 32854335 Free PMC article. Review.
-
Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.Am J Gastroenterol. 2017 Mar;112(3):460-470. doi: 10.1038/ajg.2016.480. Epub 2016 Oct 25. Am J Gastroenterol. 2017. PMID: 27779194
-
Postpartum Laboratory Follow-up in Women With Hepatitis B in Massachusetts From 2007 to 2012.J Clin Gastroenterol. 2016 Jul;50(6):e60-4. doi: 10.1097/MCG.0000000000000530. J Clin Gastroenterol. 2016. PMID: 27092430 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical